FTC's Campaign Against Improper Orange Book Listings Continu

The Federal Trade Commission ("FTC") has filed an amicus brief in Teva Branded Pharmaceuticals Products R&D, Inc. v. Amneal Pharmaceuticals of New York, LLC to further the agency's...

Related Keywords

Takeda Pharm , Amneal Pharmaceuticals Of New York , Commission Statement Concerning Brand Drug Manufacturers , Welfare Fund , Teva Branded Pharmaceuticals Products , Federal Trade Commission , New York , Abbreviated New Drug Application , Orange Book , Sherman Act , Hatch Waxman Amendments , Cosmetic Act , New Drug Application , Policy Statement , Brand Pharmaceutical , Manufacturer Improper Listing , Second Circuit , Lantus Direct , Purchaser Litigation , United Food , Trade Comm N , Improper Listing , Press Release , Challenges More Than , Improperly Listed , Mondaq , Ftc , Orange Book Listings , Antitrust Competition Law , Antitrust , U Competition , Food , Drugs , Healthcare , Life Sciences , Food And Drugs Law , Iotechnology Amp Nanotechnology , Intellectual Property , Patent , ,